5-Amino-1MQ: What It Is (Research Overview)

Despite often being grouped with peptides, 5-Amino-1MQ is NOT a peptide.

It is a small-molecule NNMT inhibitor (nicotinamide N-methyltransferase inhibitor) studied in metabolic research. (Prof. Peptide)

---

How it works (scientific mechanism)

Researchers study it because it blocks the enzyme NNMT, which:

• consumes nicotinamide (vitamin B3 derivative)
• influences NAD+ metabolism
• is linked to fat storage and metabolic efficiency

By inhibiting NNMT, lab studies suggest potential effects on:

• NAD+ availability
• fat cell metabolism
• energy regulation pathways (PeptideInsight)

---

What it’s studied for

In preclinical (cell + animal) research only:

• obesity & fat metabolism models
• insulin sensitivity pathways
• mitochondrial energy regulation
• aging/metabolic stress research (PeptideInsight)

---

Important reality check

• ❌ No approved medical use
• ❌ No completed human clinical trials
• ❌ No established safe dosing in humans
• ⚠️ All results are preclinical (not proven in humans) (PeptideWise)

---

Key takeaway

5-Amino-1MQ is a lab-stage metabolic research compound, not a supplement or approved drug, and its effects in humans are still unknown.

---